Home/Filings/4/0001405626-18-000004
4//SEC Filing

Corin Denis 4

Accession 0001405626-18-000004

CIK 0001596062other

Filed

Jun 27, 8:00 PM ET

Accepted

Jun 28, 10:26 AM ET

Size

7.9 KB

Accession

0001405626-18-000004

Insider Transaction Report

Form 4
Period: 2018-06-25
CORIN DENIS
DirectorChief Executive Officer10% Owner
Transactions
  • Sale

    Common Stock

    2018-06-25$3.42/sh1,400$4,7852,489,600 total
  • Sale

    Common Stock

    2018-06-27$3.44/sh4,900$16,8332,480,900 total
  • Sale

    Common Stock

    2018-06-26$3.43/sh3,800$13,0332,485,800 total
Footnotes (1)
  • [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 1, 2018 for the sale of up to 139,871 shares of common stock. Such sales were outside the Reporting Person's investment decision.

Issuer

Q BioMed Inc.

CIK 0001596062

Entity typeother

Related Parties

1
  • filerCIK 0001405626

Filing Metadata

Form type
4
Filed
Jun 27, 8:00 PM ET
Accepted
Jun 28, 10:26 AM ET
Size
7.9 KB